{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:54:41Z","timestamp":1792169681425,"version":"4.4.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.leukres.2026.108343","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:54:33Z","timestamp":1791906873000},"page":"108343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Megakaryopoiesis and its dysregulation in paediatric acute megakaryoblastic leukaemia"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9067-0108","authenticated-orcid":false,"given":"Faakhir","family":"Butt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0474-5843","authenticated-orcid":false,"given":"Marry","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9150-8026","authenticated-orcid":false,"given":"Jacqueline","family":"Cloos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca F.","family":"Goemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1346-6606","authenticated-orcid":false,"given":"Tom","family":"Reuvekamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.leukres.2026.108343_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1158\/2159-8290.CD-21-1094","article-title":"A summary of the inaugural WHO classification of pediatric tumors: transitioning from the optical into the molecular era","volume":"12","author":"Pfister","year":"2022","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.leukres.2026.108343_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s43042-024-00563-w","article-title":"Prognosis and treatment in acute myeloid leukemia: a comprehensive review","volume":"25","author":"Debnath","year":"2024","journal-title":"Egypt. J. Med. Human. Genet."},{"issue":"1","key":"10.1016\/j.leukres.2026.108343_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nm.4439","article-title":"The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions","volume":"24","author":"Bolouri","year":"2018","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.leukres.2026.108343_bib4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/08880018.2025.2453861","article-title":"Pediatric AML: state of the art and future directions","volume":"42","author":"Iyer","year":"2025","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.leukres.2026.108343_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ph16111614","article-title":"A review of childhood acute myeloid leukemia: diagnosis and novel treatment","volume":"16","author":"Tseng","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"14","key":"10.1016\/j.leukres.2026.108343_bib6","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1182\/blood.2024027904","article-title":"Diagnosis and management of AML in pediatric patients: consensus recommendations from an international expert panel","volume":"147","author":"Zwaan","year":"2026","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2026.108343_bib7","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2026.108343_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.leukres.2026.108343_bib9","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.leukres.2026.108343_bib10","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.3324\/haematol.2024.285644","article-title":"Novel classification system and high-risk categories of pediatric acute myeloid leukemia","volume":"110","author":"Umeda","year":"2025","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.leukres.2026.108343_bib11","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"Dohner","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2026.108343_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-3-031-27156-4_10","article-title":"Targeted therapy and personalized medicine","volume":"185","author":"Saeed","year":"2023","journal-title":"Cancer Treat. Res."},{"issue":"20","key":"10.1016\/j.leukres.2026.108343_bib13","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1182\/bloodadvances.2019000404","article-title":"Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia","volume":"3","author":"Shiba","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.leukres.2026.108343_bib14","series-title":"Standard of Care and Future Perspectives","first-page":"19","article-title":"Chromosomal and Genomic Alterations in Pediatric AML","author":"Lamble","year":"2024"},{"issue":"9","key":"10.1016\/j.leukres.2026.108343_bib15","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes","volume":"26","author":"van Dongen","year":"2012","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.leukres.2026.108343_bib16","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood.2025031480","article-title":"2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party","volume":"147","author":"Cloos","year":"2026","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2026.108343_bib17","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/sj.leu.2402618","article-title":"Acute megakaryoblastic leukemia: experience of GIMEMA trials","volume":"16","author":"Pagano","year":"2002","journal-title":"Leukemia"},{"issue":"21","key":"10.1016\/j.leukres.2026.108343_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17213511","article-title":"Pediatric non-down syndrome acute megakaryoblastic leukemia patients have dismal outcomes irrespective of allogeneic hematopoietic stem cell transplant: a single-center experience","volume":"17","author":"Llaurador","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.leukres.2026.108343_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061583","article-title":"Immunophenotypic analysis of acute megakaryoblastic leukemia: a EuroFlow study","volume":"14","author":"Brouwer","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.leukres.2026.108343_bib20","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1182\/blood.V97.12.3727","article-title":"Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience","volume":"97","author":"Athale","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2026.108343_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/pbc.20951","article-title":"Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group","volume":"49","author":"Barnard","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"issue":"25","key":"10.1016\/j.leukres.2026.108343_bib22","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1182\/blood-2017-01-764324","article-title":"Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial","volume":"129","author":"Taub","year":"2017","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.leukres.2026.108343_bib23","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1182\/blood-2017-01-765057","article-title":"Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trial","volume":"129","author":"Uffmann","year":"2017","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.leukres.2026.108343_bib24","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood.2021012206","article-title":"High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial","volume":"138","author":"Hitzler","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2026.108343_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/blood.2025030775","article-title":"CPX-351 in Down syndrome-associated myeloid leukemia: results and prognostic factors from the phase ML-DS 2018 trial","volume":"147","author":"Laszig","year":"2026","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2026.108343_bib26","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00277-015-2383-2","article-title":"Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial","volume":"94","author":"Schweitzer","year":"2015","journal-title":"Ann. Hematol."},{"issue":"2","key":"10.1016\/j.leukres.2026.108343_bib27","first-page":"608","article-title":"Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with down syndrome: Children's Cancer Group Studies 2861 and 2891","volume":"91","author":"Lange","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2026.108343_bib28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.3772","article-title":"Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes","volume":"49","author":"de Rooij","year":"2017","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.leukres.2026.108343_bib29","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/sj.leu.2403814","article-title":"AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity","volume":"19","author":"Creutzig","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2026.108343_bib30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.critrevonc.2019.04.011","article-title":"The changing scenario of non-down syndrome acute megakaryoblastic leukemia in children","volume":"138","author":"Masetti","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"19","key":"10.1016\/j.leukres.2026.108343_bib31","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.1128\/MCB.25.19.8592-8606.2005","article-title":"GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1","volume":"25","author":"Kuhl","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.leukres.2026.108343_bib32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-3-031-62731-6_12","article-title":"GATA1 in normal and pathologic megakaryopoiesis and platelet development","volume":"1459","author":"Takasaki","year":"2024","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.leukres.2026.108343_bib33","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1172\/JCI113277","article-title":"Platelet glycoprotein IIb. Chromosomal localization and tissue expression","volume":"80","author":"Bray","year":"1987","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.leukres.2026.108343_bib34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0006-291X(88)80884-2","article-title":"Isolation of the human platelet glycoprotein IIb gene and characterization of the 5\u2032 flanking region","volume":"156","author":"Prandini","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.leukres.2026.108343_bib35","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1016\/S0021-9258(19)50595-6","article-title":"A spontaneous mutation of integrin alpha IIb beta 3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site","volume":"267","author":"Bajt","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.leukres.2026.108343_bib36","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1182\/blood.V91.12.4397","article-title":"Bernard-Soulier syndrome","volume":"91","author":"Lopez","year":"1998","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2026.108343_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11123248","article-title":"Emerging and future targeted therapies for pediatric acute myeloid leukemia: targeting the leukemia stem cells","volume":"11","author":"Murphy","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.leukres.2026.108343_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.775128","article-title":"Leukemic stem cells: from leukemic niche biology to treatment opportunities","volume":"12","author":"Marchand","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.leukres.2026.108343_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/08880018.2010.528171","article-title":"High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia","volume":"28","author":"Witte","year":"2011","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.leukres.2026.108343_bib40","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/bjh.14991","article-title":"Leukaemic stem cell load at diagnosis predicts the development of relapse in young acute myeloid leukaemia patients","volume":"183","author":"Hanekamp","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2026.108343_bib41","doi-asserted-by":"crossref","DOI":"10.1200\/GO-25-00443","article-title":"Validation and refinement of the European LeukemiaNet 2022 Genetic Risk Stratification of AML","volume":"12","author":"Mawalankar","year":"2026","journal-title":"JCO Glob. Oncol."},{"issue":"6","key":"10.1016\/j.leukres.2026.108343_bib42","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.stem.2007.10.001","article-title":"Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood","volume":"1","author":"Majeti","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.leukres.2026.108343_bib43","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1038\/s41467-018-04441-z","article-title":"A revised road map for the commitment of human cord blood CD34-negative hematopoietic stem cells","volume":"9","author":"Sumide","year":"2018","journal-title":"Nat. Commun."},{"issue":"6039","key":"10.1016\/j.leukres.2026.108343_bib44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.1201219","article-title":"Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment","volume":"333","author":"Notta","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.leukres.2026.108343_bib45","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8532.1","article-title":"The regulation of hematopoietic stem cell populations","volume":"5","author":"Mayani","year":"2016","journal-title":"F1000Res"},{"issue":"6","key":"10.1016\/j.leukres.2026.108343_bib46","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1182\/blood.2022018071","article-title":"Human CD34+ hematopoietic stem cell hierarchy: how far are we with its delineation at the most primitive level?","volume":"142","author":"Anjos-Afonso","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2026.108343_bib47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood-2016-09-740654","article-title":"Distinct signaling programs control human hematopoietic stem cell survival and proliferation","volume":"129","author":"Knapp","year":"2017","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2026.108343_bib48","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/1074-7613(94)90037-X","article-title":"The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype","volume":"1","author":"Morrison","year":"1994","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.leukres.2026.108343_bib49","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/ijlh.14348","article-title":"Immunophenotypic features of early haematopoietic and leukaemia stem cells","volume":"46","author":"Reuvekamp","year":"2024","journal-title":"Int. J. Lab. Hematol."},{"issue":"41","key":"10.1016\/j.leukres.2026.108343_bib50","doi-asserted-by":"crossref","first-page":"17413","DOI":"10.1073\/pnas.0909296106","article-title":"Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.leukres.2026.108343_bib51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.cll.2023.04.003","article-title":"The immunophenotypic profile of healthy human bone marrow","volume":"43","author":"Lewis","year":"2023","journal-title":"Clin. Lab. Med."},{"issue":"8","key":"10.1016\/j.leukres.2026.108343_bib52","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.3324\/haematol.2021.279636","article-title":"Sorting nexin 24 is required for alpha-granule biogenesis and cargo delivery in megakaryocytes","volume":"107","author":"Lacey","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2026.108343_bib53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/B978-0-12-385493-3.00010-3","article-title":"Immunophenotypic pattern of myeloid populations by flow cytometry analysis","volume":"103","author":"Gorczyca","year":"2011","journal-title":"Methods Cell. Biol."},{"issue":"7","key":"10.1016\/j.leukres.2026.108343_bib54","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3324\/haematol.2024.287236","article-title":"New insights into the generation and function of megakaryocytes in health and disease","volume":"110","author":"Du","year":"2025","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.leukres.2026.108343_bib55","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.immuni.2007.02.013","article-title":"Molecular evidence for hierarchical transcriptional lineage priming in fetal and adult stem cells and multipotent progenitors","volume":"26","author":"Mansson","year":"2007","journal-title":"Immunity"},{"issue":"7470","key":"10.1016\/j.leukres.2026.108343_bib56","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature12495","article-title":"Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy","volume":"502","author":"Sanjuan-Pla","year":"2013","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.leukres.2026.108343_bib57","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41590-024-01845-6","article-title":"Alternative platelet differentiation pathways initiated by nonhierarchically related hematopoietic stem cells","volume":"25","author":"Carrelha","year":"2024","journal-title":"Nat. Immunol."},{"issue":"7687","key":"10.1016\/j.leukres.2026.108343_bib58","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature25168","article-title":"Clonal analysis of lineage fate in native haematopoiesis","volume":"553","author":"Rodriguez-Fraticelli","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.leukres.2026.108343_bib59","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s41556-023-01137-5","article-title":"Epigenetic programming defines haematopoietic stem cell fate restriction","volume":"25","author":"Meng","year":"2023","journal-title":"Nat. Cell. Biol."},{"issue":"6","key":"10.1016\/j.leukres.2026.108343_bib60","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1084\/jem.20091318","article-title":"Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment","volume":"207","author":"Morita","year":"2010","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.leukres.2026.108343_bib61","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1074-7613(01)00220-5","article-title":"Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity","volume":"15","author":"Adolfsson","year":"2001","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.leukres.2026.108343_bib62","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood-2004-06-2159","article-title":"Identification of Lin(-)Sca1(+)kit(+)CD34(+)Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients","volume":"105","author":"Yang","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2026.108343_bib63","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/2023","article-title":"A newly discovered class of human hematopoietic cells with SCID-repopulating activity","volume":"4","author":"Bhatia","year":"1998","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.leukres.2026.108343_bib64","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.stem.2013.05.025","article-title":"CD34(-) cells at the apex of the human hematopoietic stem cell hierarchy have distinctive cellular and molecular signatures","volume":"13","author":"Anjos-Afonso","year":"2013","journal-title":"Cell. Stem Cell."},{"issue":"3","key":"10.1016\/j.leukres.2026.108343_bib65","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.immuni.2024.02.006","article-title":"Differentiation route determines the functional outputs of adult megakaryopoiesis","volume":"57","author":"Li","year":"2024","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.leukres.2026.108343_bib66","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1038\/s41467-022-31914-z","article-title":"Fate mapping of hematopoietic stem cells reveals two pathways of native thrombopoiesis","volume":"13","author":"Morcos","year":"2022","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.leukres.2026.108343_bib67","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood.2021010697","article-title":"Single-cell analysis of ploidy and the transcriptome reveals functional and spatial divergency in murine megakaryopoiesis","volume":"138","author":"Sun","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2026.108343_bib68","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.stem.2020.11.006","article-title":"Decoding human megakaryocyte development","volume":"28","author":"Wang","year":"2021","journal-title":"Cell. Stem Cell."},{"issue":"15","key":"10.1016\/j.leukres.2026.108343_bib69","article-title":"Characterization of cellular heterogeneity and an immune subpopulation of human megakaryocytes","volume":"8","author":"Liu","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"issue":"2","key":"10.1016\/j.leukres.2026.108343_bib70","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.scr.2013.05.007","article-title":"Megakaryocytes co-localise with hemopoietic stem cells and release cytokines that up-regulate stem cell proliferation","volume":"11","author":"Heazlewood","year":"2013","journal-title":"Stem Cell. Res."},{"issue":"2","key":"10.1016\/j.leukres.2026.108343_bib71","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/CIRCRESAHA.121.319821","article-title":"Platelet and megakaryocyte roles in innate and adaptive immunity","volume":"130","author":"Koupenova","year":"2022","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.leukres.2026.108343_bib72","doi-asserted-by":"crossref","DOI":"10.1097\/BS9.0000000000000212","article-title":"Versatility of megakaryocytes in homeostasis and disease","volume":"6","author":"Wang","year":"2024","journal-title":"Blood Sci."},{"issue":"14","key":"10.1016\/j.leukres.2026.108343_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/cells14141053","article-title":"Immune and inflammatory properties of megakaryocytes","volume":"14","author":"Singh","year":"2025","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.leukres.2026.108343_bib74","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1084\/jem.20121343","article-title":"Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models","volume":"209","author":"Thiollier","year":"2012","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.leukres.2026.108343_bib75","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/bloodadvances.2022008899","article-title":"CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216","volume":"8","author":"Gress","year":"2024","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.leukres.2026.108343_bib76","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ijc.34684","article-title":"The relevance of the hematopoietic niche for therapy resistance in acute myeloid leukemia","volume":"154","author":"Allert","year":"2024","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.leukres.2026.108343_bib77","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/nm.3706","article-title":"Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells","volume":"20","author":"Zhao","year":"2014","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.leukres.2026.108343_bib78","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nm.3707","article-title":"Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion","volume":"20","author":"Bruns","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.leukres.2026.108343_bib79","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.exphem.2017.12.010","article-title":"Megakaryocyte-derived excessive transforming growth factor beta1 inhibits proliferation of normal hematopoietic stem cells in acute myeloid leukemia","volume":"60","author":"Gong","year":"2018","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108343_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-16312-x","article-title":"Exploring the effect of canine cancer-associated fibroblasts on T cell dynamics through the CXCL12\/CXCR4 axis modulated by TGF-beta1","volume":"15","author":"Kudo","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.leukres.2026.108343_bib81","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood-2006-05-024844","article-title":"CXCR4 is a prognostic marker in acute myelogenous leukemia","volume":"109","author":"Spoo","year":"2007","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.leukres.2026.108343_bib82","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1182\/blood-2008-05-158311","article-title":"Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML","volume":"113","author":"Zeng","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2026.108343_bib83","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3389\/fonc.2020.01672","article-title":"Targeting CXCR4 in AML and ALL","volume":"10","author":"Cancilla","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.leukres.2026.108343_bib84","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: opposing activities that mediate cell death","volume":"9","author":"Youle","year":"2008","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.leukres.2026.108343_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2021.100850","article-title":"Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities","volume":"50","author":"O'Reilly","year":"2021","journal-title":"Blood Rev."},{"issue":"6","key":"10.1016\/j.leukres.2026.108343_bib86","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1349-7006.1994.tb02400.x","article-title":"Loss of heterozygosity at the bcl-2 gene locus and expression of bcl-2 in human gastric and colorectal carcinomas","volume":"85","author":"Ayhan","year":"1994","journal-title":"Jpn J. Cancer Res."},{"issue":"3","key":"10.1016\/j.leukres.2026.108343_bib87","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1081\/CNV-120001177","article-title":"Apoptosis and expression of Bcl-2, Bcl-XL, and Bax in renal cell carcinomas","volume":"20","author":"Gobe","year":"2002","journal-title":"Cancer Invest."},{"issue":"5-6","key":"10.1016\/j.leukres.2026.108343_bib88","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/10428199809058365","article-title":"BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine","volume":"28","author":"Zaja","year":"1998","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.leukres.2026.108343_bib89","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41392-025-02176-0","article-title":"The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy","volume":"10","author":"Vogler","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.leukres.2026.108343_bib90","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2025.288178","article-title":"Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed\/refractory acute myeloid leukemia","author":"Verdeyen","year":"2025","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.leukres.2026.108343_bib91","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","article-title":"BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells","volume":"12","author":"Lagadinou","year":"2013","journal-title":"Cell. Stem Cell."},{"issue":"21","key":"10.1016\/j.leukres.2026.108343_bib92","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood.2024025409","article-title":"Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations","volume":"144","author":"Dohner","year":"2024","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2026.108343_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30335","article-title":"Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies","volume":"70","author":"Marinoff","year":"2023","journal-title":"Pediatr. Blood Cancer"},{"issue":"4","key":"10.1016\/j.leukres.2026.108343_bib94","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","article-title":"Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia","volume":"10","author":"Pei","year":"2020","journal-title":"Cancer Discov."},{"issue":"13","key":"10.1016\/j.leukres.2026.108343_bib95","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1182\/blood.2021011094","article-title":"Erythroid\/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia","volume":"141","author":"Kuusanm\u00e4ki","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2026.108343_bib96","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41375-022-01800-0","article-title":"High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia","volume":"37","author":"Aid","year":"2023","journal-title":"Leukemia"},{"issue":"17","key":"10.1016\/j.leukres.2026.108343_bib97","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1182\/blood-2012-11-469825","article-title":"CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype","volume":"121","author":"Masetti","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2026.108343_bib98","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30251","article-title":"Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: a report from the Children's Oncology Group","volume":"70","author":"Chisholm","year":"2023","journal-title":"Pediatr. Blood Cancer"},{"issue":"15","key":"10.1016\/j.leukres.2026.108343_bib99","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1200\/JCO.21.02188","article-title":"Addition of navitoclax to ongoing ruxolitinib therapy for patients with myelofibrosis with progression or suboptimal response: Phase II safety and efficacy","volume":"40","author":"Harrison","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.leukres.2026.108343_bib100","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.2022019246","article-title":"Is BCL-xL the Achilles' heel of AEL and AMKL?","volume":"141","author":"Brown","year":"2023","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2026.108343_bib101","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000935","article-title":"The MLL-menin interaction is a therapeutic vulnerability in NUP98-rearranged AML","volume":"7","author":"Rasouli","year":"2023","journal-title":"Hemasphere"},{"issue":"22","key":"10.1016\/j.leukres.2026.108343_bib102","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1182\/bloodadvances.2022008503","article-title":"Targeting FOLR1 in high-risk CBF2AT3-GLIS2 pediatric AML with STRO-002 FOLR1-antibody-drug conjugate","volume":"6","author":"Tang","year":"2022","journal-title":"Blood Adv."},{"issue":"22","key":"10.1016\/j.leukres.2026.108343_bib103","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157101","article-title":"CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target","volume":"132","author":"Le","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.leukres.2026.108343_bib104","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41571-020-0339-5","article-title":"Exploiting the folate receptor alpha in oncology","volume":"17","author":"Scaranti","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.leukres.2026.108343_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bneo.2026.100232","article-title":"Fully human anti-FOLR1 T-cell engager demonstrates potent activity in CBFA2T3::GLIS2 acute megakaryoblastic leukemia","volume":"3","author":"Morris","year":"2026","journal-title":"Blood Neoplasia"},{"key":"10.1016\/j.leukres.2026.108343_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.906698","article-title":"Megakaryocytes are regulators of the tumor microenvironment and malignant hematopoietic progenitor cells in myelofibrosis","volume":"12","author":"Varricchio","year":"2022","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2026.108343_bib107","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1538-7836.2011.04571.x","article-title":"Megakaryocytes, malignancy and bone marrow vascular niches","volume":"10","author":"Psaila","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.leukres.2026.108343_bib108","first-page":"2942","article-title":"Different features of acute myeloid leukemia stem cell quantification in intensively treated patients","volume":"110","author":"Ngai","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2026.108343_bib109","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/blood-2024-205457","article-title":"Flow MRD monitoring combining Laip\/Dfn and CD34+CD38- LSCs is a strong predictor of outcome in adult AML independently of the ELN-2022 risk: first results from the multicentric acute leukemia French intergroup MRD flow network","volume":"144","author":"Plesa","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2026.108343_bib110","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1182\/blood-2024-199036","article-title":"Leukemic stem cell measurable residual disease (LSC MRD) status is a better predictor of relapse than multiparametric flowcytometric analysis in acute myeloid leukemia patients","volume":"144","author":"Mawalankar","year":"2024","journal-title":"Blood"},{"issue":"40","key":"10.1016\/j.leukres.2026.108343_bib111","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ado7120","article-title":"BCL-X(L)-targeting antibody-drug conjugates are active in preclinical models and mitigate on-mechanism toxicity of small-molecule inhibitors","volume":"10","author":"Judd","year":"2024","journal-title":"Sci. Adv."},{"issue":"16_suppl","key":"10.1016\/j.leukres.2026.108343_bib112","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1200\/JCO.2023.41.16_suppl.3027","article-title":"Mirzotamab clezutoclax as monotherapy and in combination with taxane therapy in relapsed\/refractory solid tumors: dose expansion results","volume":"41","author":"Carneiro","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"15_suppl","key":"10.1016\/j.leukres.2026.108343_bib113","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1200\/JCO.2021.39.15_suppl.3015","article-title":"A first-in-human study of mirzotamab clezutoclax as monotherapy and in combination with taxane therapy in relapsed\/refractory solid tumors: dose escalation results","volume":"39","author":"Tolcher","year":"2021","journal-title":"J. Clin. Oncol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626001876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626001876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:38:25Z","timestamp":1792168705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212626001876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":113,"alternative-id":["S0145212626001876"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108343","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Megakaryopoiesis and its dysregulation in paediatric acute megakaryoblastic leukaemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108343"}}